Morgan Stanley increased its stake in Eli Lilly stock, and the company filed required reports with the SEC.
4 reports, 2 independent
Updated Sep 11
Gone quiet
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley increased its stake in Eli Lilly stock, and the company filed required reports with the SEC.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Morgan Stanley increased its investment stake in Eli Lilly stock, requiring a Form 13F filing with the SEC.1 source
Morgan Stanley increased its stake in Eli Lilly, filing required reports with the SEC.1 source
Keep exploring
The entities involved
-
Morgan Stanley
U.S. investment bank
-
Eli Lilly and Company
American pharmaceutical company
Related events
- Bank of America and Norges Bank purchased new stakes in Eli Lilly and Company on September 10, 2026.
- Eli Lilly and Company filed a disclosure with the Securities and Exchange Commission on June 15, 2026.
- Eli Lilly and Company filed institutional holdings reports with the SEC, while Bank of America raised price targets on the stock.
- Morgan Stanley issued research reports and price targets, while institutional investment disclosures were filed with the SEC regarding a new stake purchase in Stanley Black & Decker.
- Lockheed Martin filed required reports with the SEC while Morgan Stanley increased its stake in the company during Q4.